Results 251 to 260 of about 19,525,905 (384)

Discussion: “Pre-Exhaust-Gas-Pressure Measurements for Indicating Diesel-Engine Performance” (Jennings, B. H., and Jackson, T. E., 1942, Trans. ASME, 64, pp. 331–335) [PDF]

, 1942
Carl A. Jacobson
openalex   +1 more source

Data Fusion for Signalized Arterial Performance Measurement - ATSPM Dataset

, 2023
Shoaib Samandar
openalex   +1 more source

Performance measurement approach for innovation capability in SMEs

, 2016
Minna Saunila
semanticscholar   +1 more source

Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway

Molecular Oncology, EarlyView.
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed, Kerstin Huebner, Katharina Erlenbach‐Wuensch, Chuanpit Hampel, Daniela Thalheim, Adriana Vial‐Roehe, Bodee Nutho, Susanne Merkel, Arndt Hartmann, Pithi Chanvorachote, Regine Schneider‐Stock   +10 more
wiley   +1 more source

Performance measurement systems and metrics: a framework for monitoring oil operations

, 2013
A. A. Noura, Rebecca De Coster
openalex   +1 more source

Performance Measurement in UK textile & clothingmanufacturing SMEs: Regaining the initiative [PDF]

, 2005
Sharp Cooper
openalex  

Class IIa HDACs forced degradation allows resensitization of oxaliplatin‐resistant FBXW7‐mutated colorectal cancer

Molecular Oncology, EarlyView.
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto, Nicolò Gualandi, Ylenia Cortolezzis, Raffaella Picco, Monica Colitti, Francesca D'Este, Mariachiara Gani, Wayne W. Hancock, Giovanni Terrosu, Cristina Degrassi, Francesca Agostini, Claudio Brancolini, Luigi E. Xodo, Eros Di Giorgio   +13 more
wiley   +1 more source

A transparent and standardized performance measurement platform is needed for on-prescription digital health apps to enable ongoing performance monitoring. [PDF]

PLOS Digit Health
Welzel C, Brückner S, Brightwell C, Fenech M, Gilbert S.   +4 more
europepmc   +1 more source

In vitro models of cancer‐associated fibroblast heterogeneity uncover subtype‐specific effects of CRISPR perturbations

Molecular Oncology, EarlyView.
Development of therapies targeting cancer‐associated fibroblasts (CAFs) necessitates preclinical model systems that faithfully represent CAF–tumor biology. We established an in vitro coculture system of patient‐derived pancreatic CAFs and tumor cell lines and demonstrated its recapitulation of primary CAF–tumor biology with single‐cell transcriptomics ...
Elysia Saputra, Shamsudheen Karuthedath Vellarikkal, Lixia Li, Hong Sun, Khoa Nguyen, Amber Montano, Suchitra Natarajan, Federica Piccioni, Alex Michael Tamburino, Xin Yu, Aleksandra Katarzyna Olow   +10 more
wiley   +1 more source

Venous thromboembolism performance measurement in the United States: An evolving landscape with many stakeholders. [PDF]

J Hosp Med
Braun BI, Kolbusz KM, Bozikis MR, Schmaltz SP, Abe K, Reyes NL, Dardis MN.   +6 more
europepmc   +1 more source